Skip to content

WRA

Active
Private limited companyfounded 2020active for 5 yearsVijverlaan 3, 3010 Leuven, BelgiumKBO/BCE: BE 0758.728.258
Summary

WRA has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1,000 and a net result of €50,053. Equity is shrinking by about 29% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 6% of 20,320 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
1 site
Size
€52,231total assets 2025
Equity
€1,000
Profit
€50,053
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 63 days early1 of 3 deeds read
Why 91raises riskEquity €1,000 (1.9% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.89, cash €28,480Size: total assets €52,231Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 30% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 27-1
equity 1.9% of total assets
Liquidity 50=
short-term debt 98.1% · cash 54.5%
Profitability 100=
return on assets 95.8%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,036 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 7% on solvency, 20% on liquidity, 80% on profitability and 12% on growth.

The bankruptcy probability was computed on 11-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.89, cash €28,480
NBB · annual accounts
raises risk · Equity €1,000 (1.9% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €52,231
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 20320 sector peers (2025).
NBB · sector comparison
Position among 20320 sector peers
Solvency
better than 6%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
63 days early
2024
28 days early
2023
6 days early
2022
on the day
2021
10 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 17 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 July (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
12-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Appointment: Naomi Schreurs (director)Related document
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Caution: Among the weakest 5% on equitysector median €123,937 · 20,323 companies €1,000 View
  • New directorlatest change 01-02-2026 · 1 in office 1 joined View
  • Positive: 5 profitable years in a rowprofit 2025: €50,053 5 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Total assets
€52,231
Profit
€50,053
Solvency
1.9%
Total assets▼ 24.0%
Net result
20212025
Go to Financials

Timeline

Events
10
Since
2022
Next accounts
by 31-07-2027
  1. 25-07-2024Annual accounts filed
  2. 31-12-2023Weakest financial year
  3. 31-12-2023Liquidity more than doubled
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Medical imaging and medical laboratoriesNACE 86910
Founded
24-11-2020
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.